Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Jul 17;7(9):4284–4295. doi: 10.1002/cam4.1674

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2018 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

CD5 Expression, CD43 Expression, and CD5/CD43 Coexpression in DLBCL are all Prognostic Factors Independently of Chemotherapy With or Without Rituximab. (A, D) Overall survival according to CD5 expression and chemotherapy with rituximab (D) or without rituximab (A). (B, E) Overall survival according to CD43 expression and chemotherapy with rituximab (E) or without rituximab (B). (C, F) Overall survival according to CD5/CD43 coexpression and chemotherapy with rituximab (F) or without rituximab (C)